Current perspectives on the role of IL-17 in autoimmune disease

References

• RouvierELucianiMFMatteiMGDenizotFGolsteinPCTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri geneJ Immunol199315012544554568390535
   PubMed Web of Science ®Google Scholar
• YaoZPainterSLFanslowWCHuman IL-17: A novel cytokine derived from T cellsJ Immunol199515512548354867499828
   PubMed Web of Science ®Google Scholar
• de JongESuddasonTLordGMTranslational mini-review series on Th17 cells: Development of mouse and human T helper 17 cellsClin Exp Immunol2009159214815819912248
   PubMed Web of Science ®Google Scholar
• FossiezFDjossouOChomaratPT cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokinesJ Exp Med19961836259326038676080
   PubMed Web of Science ®Google Scholar
• MatsuzakiGUmemuraMInterleukin-17 as an effector molecule of innate and acquired immunity against infectionsMicrobiol Immunol200751121139114718094532
   PubMed Web of Science ®Google Scholar
• LiangSCTanXYLuxenbergDPInterleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptidesJ Exp Med2006203102271227916982811
   PubMed Web of Science ®Google Scholar
• Acosta-RodriguezEVRivinoLGeginatJSurface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cellsNat Immunol20078663964617486092
   PubMed Web of Science ®Google Scholar
• PaulsonMLFreemanAFHollandSMHyper IgE syndrome: An update on clinical aspects and the role of signal transducer and activator of transcription 3Curr Opin Allergy Clin Immunol20088652753318978467
   PubMed Web of Science ®Google Scholar
• JovanovicDVDi BattistaJAMartel-PelletierJIL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophagesJ Immunol19981607351335219531313
   PubMed Web of Science ®Google Scholar
• JovanovicDVMartel-PelletierJDi BattistaJAStimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin- 17 in human monocyte/macrophages: A possible role in rheumatoid arthritisArthritis Rheum20004351134114410817568
   PubMed Web of Science ®Google Scholar
• KotakeSUdagawaNTakahashiNIL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisJ Clin Invest199910391345135210225978
   PubMed Web of Science ®Google Scholar
• YagiYAndohAInatomiOTsujikawaTFujiyamaYInflammatory responses induced by interleukin-17 family members in human colonic subepithelial myofibroblastsJ Gastroenterol200742974675317876544
   PubMed Web of Science ®Google Scholar
• AlbanesiCScarponiCCavaniAInterleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma-and interleukin-4-induced activation of human keratinocytesJ Invest Dermatol20001151818710886512
   PubMed Web of Science ®Google Scholar
• KebirHKreymborgKIferganIHuman TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammationNat Med200713101173117517828272
   PubMed Web of Science ®Google Scholar
• AarvakTChabaudMMiossecPNatvigJBIL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cellsJ Immunol19991623124612519973376
   PubMed Web of Science ®Google Scholar
• AnnunziatoFCosmiLSantarlasciVPhenotypic and functional features of human Th17 cellsJ Exp Med200720481849186117635957
   PubMed Web of Science ®Google Scholar
• YangXOPappuBPNurievaRT helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gammaImmunity2008281293918164222
   PubMed Web of Science ®Google Scholar
• Acosta-RodriguezEVNapolitaniGLanzavecchiaASallustoFInterleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cellsNat Immunol20078994294917676045
   PubMed Web of Science ®Google Scholar
• SantarlasciVMaggiLCaponeMTGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cellsEur J Immunol200939120721519130583
   PubMed Web of Science ®Google Scholar
• CosmiLDe PalmaRSantarlasciVHuman interleukin 17-producing cells originate from a CD161+CD4+ T cell precursorJ Exp Med200820581903191618663128
   PubMed Web of Science ®Google Scholar
• MichelMLKellerACPagetCIdentification of an IL-17- producing NK1.1(neg) iNKT cell population involved in airway neutrophiliaJ Exp Med20072045995100117470641
   PubMed Web of Science ®Google Scholar
• HirotaKYoshitomiHHashimotoMPreferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal modelJ Exp Med200720412803281218025126
   PubMed Web of Science ®Google Scholar
• NurievaRIChungYHwangDGeneration of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineagesImmunity200829113814918599325
   PubMed Web of Science ®Google Scholar
• EyerichSEyerichKPenninoDTh22 cells represent a distinct human T cell subset involved in epidermal immunity and remodelingJ Clin Invest2009119123573358519920355
   PubMed Web of Science ®Google Scholar
• TakatoriHKannoYWatfordWTLymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22J Exp Med20092061354119114665
   PubMed Web of Science ®Google Scholar
• ItoYUsuiTKobayashiSGamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritisArthritis Rheum20096082294230319644886
   PubMed Web of Science ®Google Scholar
• LeesJRIwakuraYRussellJHHost T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell linesJ Immunol2008180128066807218523270
   PubMed Web of Science ®Google Scholar
• BoumaGStroberWThe immunological and genetic basis of inflammatory bowel diseaseNat Rev Immunol20033752153312876555
   PubMed Web of Science ®Google Scholar
• HueSAhernPBuonocoreSInterleukin-23 drives innate and T cell-mediated intestinal inflammationJ Exp Med2006203112473248317030949
   PubMed Web of Science ®Google Scholar
• YenDCheungJScheerensHIL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6J Clin Invest200611651310131616670770
   PubMed Web of Science ®Google Scholar
• NoguchiEHommaYKangXNeteaMGMaXACrohn’s disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1Nat Immunol200910547147919349988
   PubMed Web of Science ®Google Scholar
• ElsonCOCongYWeaverCTMonoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in miceGastroenterology200713272359237017570211
   PubMed Web of Science ®Google Scholar
• O’ConnorWJrKamanakaMBoothCJA protective function for interleukin 17A in T cell-mediated intestinal inflammationNat Immunol200910660360919448631
   PubMed Web of Science ®Google Scholar
• YangXOChangSHParkHRegulation of inflammatory responses by IL-17FJ Exp Med200820551063107518411338
   PubMed Web of Science ®Google Scholar
• PowrieFLeachMWMauzeSMenonSCaddleLBCoffmanRLInhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cellsImmunity1994175535627600284
   PubMed Web of Science ®Google Scholar
• NielsenOHKirmanIRudigerNHendelJVainerBUpregulation of interleukin-12 and -17 in active inflammatory bowel diseaseScand J Gastroenterol200338218018512678335
   PubMed Web of Science ®Google Scholar
• FujinoSAndohABambaSIncreased expression of interleukin 17 in inflammatory bowel diseaseGut2003521657012477762
   PubMed Web of Science ®Google Scholar
• SchmidtCGieseTLudwigBExpression of interleukin-12- related cytokine transcripts in inflammatory bowel disease: Elevated interleukin-23p19 and interleukin-27p28 in Crohn’s disease but not in ulcerative colitisInflamm Bowel Dis2005111162315674109
   PubMed Web of Science ®Google Scholar
• HolttaVKlemettiPSipponenTIL-23/IL-17 immunity as a hallmark of Crohn’s diseaseInflamm Bowel Dis20081491175118418512248
   PubMed Web of Science ®Google Scholar
• AndohAZhangZInatomiOInterleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblastsGastroenterology2005129396998416143135
   PubMed Web of Science ®Google Scholar
• WolkKWitteEHoffmannUIL-22 induces lipopolysaccharide-binding protein in hepatocytes: A potential systemic role of IL-22 in Crohn’s diseaseJ Immunol200717895973598117442982
   PubMed Web of Science ®Google Scholar
• SeidererJElbenIDiegelmannJRole of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohn‘s disease and analysis of the IL17F p.His161Arg polymorphism in IBDInflamm Bowel Dis200814443744518088064
   PubMed Web of Science ®Google Scholar
• DuerrRHTaylorKDBrantSRA genome-wide association study identifies IL23R as an inflammatory bowel disease geneScience200631458041461146317068223
   PubMed Web of Science ®Google Scholar
• SatoKShiotaMFukudaSStrong evidence of a combination polymorphism of the tyrosine kinase 2 gene and the signal transducer and activator of transcription 3 gene as a DNA-based biomarker for susceptibility to Crohn’s disease in the Japanese populationJ Clin Immunol200929681582519653082
   PubMed Web of Science ®Google Scholar
• KleinschekMABonifaceKSadekovaSCirculating and gut- resident human Th17 cells express CD161 and promote intestinal inflammationJ Exp Med2009206352553419273624
   PubMed Web of Science ®Google Scholar
• FussIJHellerFBoirivantMNonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitisJ Clin Invest2004113101490149715146247
   PubMed Web of Science ®Google Scholar
• KobayashiTOkamotoSHisamatsuTIL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn’s diseaseGut200857121682168918653729
   PubMed Web of Science ®Google Scholar
• RovedattiLKudoTBiancheriPDifferential regulation of interleukin 17 and interferon gamma production in inflammatory bowel diseaseGut200958121629163619740775
   PubMed Web of Science ®Google Scholar
• KamadaNHisamatsuTOkamotoSUnique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/ IFN-gamma axisJ Clin Invest200811862269228018497880
   PubMed Web of Science ®Google Scholar
• TeunissenMBKoomenCWde Waal MalefytRWierengaEABosJDInterleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytesJ Invest Dermatol199811146456499764847
   PubMed Web of Science ®Google Scholar
• LowesMAKikuchiTFuentes-DuculanJPsoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cellsJ Invest Dermatol200812851207121118200064
   PubMed Web of Science ®Google Scholar
• ChanJRBlumenscheinWMurphyEIL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesisJ Exp Med2006203122577258717074928
   PubMed Web of Science ®Google Scholar
• WilsonNJBonifaceKChanJRDevelopment, cytokine profile and function of human interleukin 17-producing helper T cellsNat Immunol20078995095717676044
   PubMed Web of Science ®Google Scholar
• AricanOAralMSasmazSCiragilPSerum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severityMediators Inflamm20052005527327916258194
   PubMed Web of Science ®Google Scholar
• KryczekIBruceATGudjonssonJEInduction of IL-17+ T cell trafficking and development by IFN-gamma: Mechanism and pathological relevance in psoriasisJ Immunol200818174733474118802076
   PubMed Web of Science ®Google Scholar
• HomeyBDieu-NosjeanMCWiesenbornAUp-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasisJ Immunol2000164126621663210843722
   PubMed Web of Science ®Google Scholar
• LeeETrepicchioWLOestreicherJLIncreased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgarisJ Exp Med2004199112513014707118
   PubMed Web of Science ®Google Scholar
• PiskinGSylva-SteenlandRMBosJDTeunissenMBIn vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: Enhanced expression in psoriatic skinJ Immunol200617631908191516424222
   PubMed Web of Science ®Google Scholar
• CaponFDi MeglioPSzaubJSequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasisHum Genet2007122220120617587057
   PubMed Web of Science ®Google Scholar
• CargillMSchrodiSJChangMA large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genesAm J Hum Genet200780227329017236132
   PubMed Web of Science ®Google Scholar
• ZhengYDanilenkoDMValdezPInterleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosisNature2007445712864865117187052
   PubMed Web of Science ®Google Scholar
• MaHLLiangSLiJIL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammationJ Clin Invest2008118259760718202747
   PubMed Web of Science ®Google Scholar
• WolkKKunzSWitteEFriedrichMAsadullahKSabatRIL-22 increases the innate immunity of tissuesImmunity200421224125415308104
   PubMed Web of Science ®Google Scholar
• BonifaceKBernardFXGarciaMGurneyALLecronJCMorelFIL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytesJ Immunol200517463695370215749908
   PubMed Web of Science ®Google Scholar
• WolkKWitteEWallaceEIL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: A potential role in psoriasisEur J Immunol20063651309132316619290
   PubMed Web of Science ®Google Scholar
• DuhenTGeigerRJarrossayDLanzavecchiaASallustoFProduction of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cellsNat Immunol200910885786319578369
   PubMed Web of Science ®Google Scholar
• TrifariSKaplanCDTranEHCrellinNKSpitsHIdentification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cellsNat Immunol200910886487119578368
   PubMed Web of Science ®Google Scholar
• NogralesKEZabaLCGuttman-YasskyETh17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathwaysBr J Dermatol200815951092110218684158
   PubMed Web of Science ®Google Scholar
• SteinerGTohidast-AkradMWitzmannGCytokine production by synovial T cells in rheumatoid arthritisRheumatology (Oxford)1999383202213
   Web of Science ®Google Scholar
• TesmerLALundySKSarkarSFoxDATh17 cells in human diseaseImmunol Rev20082238711318613831
   PubMed Web of Science ®Google Scholar
• MurphyCALangrishCLChenYDivergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammationJ Exp Med2003198121951195714662908
   PubMed Web of Science ®Google Scholar
• NakaeSNambuASudoKIwakuraYSuppression of immune induction of collagen-induced arthritis in IL-17-deficient miceJ Immunol2003171116173617714634133
   PubMed Web of Science ®Google Scholar
• LubbertsEKoendersMIOppers-WalgreenBTreatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosionArthritis Rheum200450265065914872510
   PubMed Web of Science ®Google Scholar
• BushKAFarmerKMWalkerJSKirkhamBWReduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion proteinArthritis Rheum200246380280511920418
   PubMed Web of Science ®Google Scholar
• NakaeSSaijoSHoraiRSudoKMoriSIwakuraYIL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonistProc Natl Acad Sci U S A2003100105986599012721360
   PubMed Web of Science ®Google Scholar
• HirotaKHashimotoMYoshitomiHT cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritisJ Exp Med20072041414717227914
   PubMed Web of Science ®Google Scholar
• ChabaudMDurandJMBuchsNHuman interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synoviumArthritis Rheum199942596397010323452
   PubMed Web of Science ®Google Scholar
• HueberAJAsquithDLMillerAMCutting edge: Mast cells express IL-17A in rheumatoid arthritis synoviumJ Immunol201018473336334020200272
   PubMed Web of Science ®Google Scholar
• ZiolkowskaMKocALuszczykiewiczGHigh levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanismJ Immunol200016452832283810679127
   PubMed Web of Science ®Google Scholar
• HusseinMRFathiNAEl-DinAMAlterations of the CD4(+), CD8(+) T cell subsets, interleukins-1beta, IL-10, IL-17, tumor necrosis factor-alpha and soluble intercellular adhesion molecule-1 in rheumatoid arthritis and osteoarthritis: Preliminary observationsPathol Oncol Res200814332132818392953
   PubMed Web of Science ®Google Scholar
• MoranEMMullanRMcCormickJHuman rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: Synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapiesArthritis Res Ther.2009114R11319627579
   PubMed Web of Science ®Google Scholar
• SinghRAggarwalAMisraRTh1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiated spondyloarthropathyJ Rheumatol200734112285229017937463
   PubMed Web of Science ®Google Scholar
• AgarwalSMisraRAggarwalAInterleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metal-loproteinasesJ Rheumatol200835351551918203309
   PubMed Web of Science ®Google Scholar
• RazaKFalcianiFCurnowSJEarly rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell originArthritis Res Ther200574R78478515987480
   PubMed Web of Science ®Google Scholar
• KirkhamBWLassereMNEdmondsJPSynovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: A two-year prospective study (the DAMAGE study cohort)Arthritis Rheum20065441122113116572447
   PubMed Web of Science ®Google Scholar
• StampLKEassonAPetterssonLHightonJHessianPAMonocyte derived interleukin (IL)-23 is an important determinant of synovial IL-17A expression in rheumatoid arthritisJ Rheumatol200936112403240819797506
   PubMed Web of Science ®Google Scholar
• HillyerPLarcheMJBowmaEPInvestigating the role of the interleukin-23/-17A axis in rheumatoid arthritisRheumatology (Oxford)2009481215811589
   Web of Science ®Google Scholar
• KohnoMTsutsumiAMatsuiHInterleukin-17 gene expression in patients with rheumatoid arthritisMod Rheumatol2008181152218092129
   PubMed Web of Science ®Google Scholar
• YamadaHNakashimaYOkazakiKTh1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritisAnn Rheum Dis20086791299130418063670
   PubMed Web of Science ®Google Scholar
• JandusCBioleyGRivalsJPDudlerJSpeiserDRomeroPIncreased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritidesArthritis Rheum20085882307231718668556
   PubMed Web of Science ®Google Scholar
• BurmanAHaworthOHardieDLA chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritisJ Immunol200517431693170015661933
   PubMed Web of Science ®Google Scholar
• ColinEMAsmawidjajaPSvan HamburgJP1,25-dihydroxyvitamin D(3) modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritisArthritis Rheum201062113214220039421
   PubMed Web of Science ®Google Scholar
• KokkonenHSoderstromIRocklovJHallmansGLejonKRantapaa DahlqvistSUp-regulation of cytokines and chemokines predates the onset of rheumatoid arthritisArthritis Rheum201062238339120112361
   PubMed Web of Science ®Google Scholar
• BrentanoFOspeltCStanczykJGayREGaySKyburzDAbundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: Differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritisAnn Rheum Dis200968114315018276743
   PubMed Web of Science ®Google Scholar
• ChangMSaikiRKCantaneseJJThe inflammatory disease-associated variants in IL12B and IL23R are not associated with rheumatoid arthritisArthritis Rheum20085861877188118512797
   PubMed Web of Science ®Google Scholar
• ParkJHKimYJParkBLBaeJSShinHDBaeSCLack of association between interleukin 23 receptor gene polymorphisms and rheumatoid arthritis susceptibilityRheumatol Int200929778178619034457
   PubMed Web of Science ®Google Scholar
• BrennanFMChantryDJacksonAMainiRFeldmannMInhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritisLancet1989286572442472569055
   PubMed Web of Science ®Google Scholar
• CuaDJSherlockJChenYInterleukin-23 rather than interleukin- 12 is the critical cytokine for autoimmune inflammation of the brainNature2003421692474474812610626
   PubMed Web of Science ®Google Scholar
• KroenkeMACarlsonTJAndjelkovicAVSegalBMIL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibitionJ Exp Med200820571535154118573909
   PubMed Web of Science ®Google Scholar
• YangYWeinerJLiuYT-bet is essential for encephalitogenicity of both Th1 and Th17 cellsJ Exp Med200920671549156419546248
   PubMed Web of Science ®Google Scholar
• HaakSCroxfordALKreymborgKIL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in miceJ Clin Invest20091191616919075395
   PubMed Web of Science ®Google Scholar
• KreymborgKEtzenspergerRDumoutierLIL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitisJ Immunol2007179128098810418056351
   PubMed Web of Science ®Google Scholar
• MatuseviciusDKivisakkPHeBInterleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosisMult Scler19995210110410335518
   PubMed Web of Science ®Google Scholar
• LockCHermansGPedottiRGene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitisNat Med20028550050811984595
   PubMed Web of Science ®Google Scholar
• IshizuTOsoegawaMMeiFJIntrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosisBrain20051285988100215743872
   PubMed Web of Science ®Google Scholar
• DurelliLContiLClericoMT-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-betaAnn Neurol200965549950919475668
   PubMed Web of Science ®Google Scholar
• Brucklacher-WaldertVStuernerKKolsterMWolthausenJTolosaEPhenotypical and functional characterization of T helper 17 cells in multiple sclerosisBrain2009132123329334119933767
   PubMed Web of Science ®Google Scholar
• TzartosJSFrieseMACranerMJInterleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosisAm J Pathol2008172114615518156204
   PubMed Web of Science ®Google Scholar
• Vaknin-DembinskyABalashovKWeinerHLIL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 productionJ Immunol2006176127768777416751425
   PubMed Web of Science ®Google Scholar
• LiYChuNHuAGranBRostamiAZhangGXIncreased IL-23p19 expression in multiple sclerosis lesions and its induction in microgliaBrain2007130249050117003070
   PubMed Web of Science ®Google Scholar
• PelfreyCMRudickRACotleurACLeeJCTary-LehmannMLehmannPVQuantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine productionJ Immunol200016531641165110903775
   PubMed Web of Science ®Google Scholar
• VoskuhlRRMartinRBergmanCDalalMRuddleNHMcFarlandHFT helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytesAutoimmunity19931521371437692995
   PubMed Web of Science ®Google Scholar
• BegovichABChangMCaillierSJThe autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosisHum Immunol2007681193493718082575
   PubMed Web of Science ®Google Scholar
• NunezCDemaBCenitMCIL23R: A susceptibility locus for celiac disease and multiple sclerosis?Genes Immun20089428929318368064
   PubMed Web of Science ®Google Scholar
• RoosIMKockumIHillertJThe interleukin 23 receptor gene in multiple sclerosis: A case-control studyJ Neuroimmunol20081941–217318018164077
   PubMed Web of Science ®Google Scholar
• IllesZSafranyEPeterfalviA3′UTR C2370A allele of the IL-23 receptor gene is associated with relapsing-remitting multiple sclerosisNeurosci Lett20084311363818180107
   PubMed Web of Science ®Google Scholar
• BielekovaBGoodwinBRichertNEncephalitogenic potential of the myelin basic protein peptide (amino acids 83–99 in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligandNat Med20006101167117511017150
   PubMed Web of Science ®Google Scholar
• PanitchHSHirschRLHaleyASJohnsonKPExacerbations of multiple sclerosis in patients treated with gamma interferonLancet1987185388938952882294
   PubMed Web of Science ®Google Scholar
• SenoltLVencovskyJPavelkaKOspeltCGaySProspective new biological therapies for rheumatoid arthritisAutoimmun Rev20099210210719328245
   PubMed Web of Science ®Google Scholar
• TarganSRHanauerSBvan DeventerSJA short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn‘s disease. Crohn’s Disease cA2 Study GroupN Engl J Med199733715102910359321530
   PubMed Web of Science ®Google Scholar
• ReichKNestleFOPappKInfliximab induction and maintenance therapy for moderate-to-severe psoriasis: A phase III, multicentre, double-blind trialLancet200536694941367137416226614
   PubMed Web of Science ®Google Scholar
• van OostenBWBarkhofFTruyenLIncreased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2Neurology1996476153115348960740
   PubMed Web of Science ®Google Scholar
• ShariefMKHentgesRAssociation between tumor necrosis factor- alpha and disease progression in patients with multiple sclerosisN Engl J Med199132574674721852181
   PubMed Web of Science ®Google Scholar
• SelmajKWRaineCSTumor necrosis factor mediates myelin and oligodendrocyte damage in vitroAnn Neurol19882343393463132891
   PubMed Web of Science ®Google Scholar
• RuddleNHBergmanCMMcGrathKMAn antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitisJ Exp Med19901724119312002212948
   PubMed Web of Science ®Google Scholar
• KornerHRimintonDSStricklandDHLemckertFAPollardJDSedgwickJDCritical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targetingJ Exp Med19971869158515909348316
   PubMed Web of Science ®Google Scholar
• KageyamaYKobayashiHKatoNInfliximab treatment reduces the serum levels of interleukin-23 in patients with rheumatoid arthritisMod Rheumatol200919665766219685204
   PubMed Web of Science ®Google Scholar
• YueCYouXZhaoLThe effects of adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patientsRheumatol Int20091022 [Epub ahead of print]
   Web of Science ®Google Scholar
• ZabaLCCardinaleIGilleaudeauPAmelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responsesJ Exp Med2007204133183319418039949
   PubMed Web of Science ®Google Scholar
• MainiRNTaylorPCSzechinskiJDouble-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexateArthritis Rheum20065492817282916947782
   PubMed Web of Science ®Google Scholar
• FujimotoMSeradaSMiharaMInterleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responsesArthritis Rheum200858123710371919035481
   PubMed Web of Science ®Google Scholar
• MertensMSinghJAAnakinra for rheumatoid arthritis: A systematic reviewJ Rheumatol20093661118112519447938
   PubMed Web of Science ®Google Scholar
• GuoBChangEYChengGThe type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in miceJ Clin Invest200811851680169018382764
   PubMed Web of Science ®Google Scholar
• PrinzMSchmidtHMildnerADistinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous systemImmunity200828567568618424188
   PubMed Web of Science ®Google Scholar
• RamgolamVSShaYJinJZhangXMarkovic-PleseSIFN-beta inhibits human Th17 cell differentiationJ Immunol200918385418542719783688
   PubMed Web of Science ®Google Scholar
• DrulovicJSavicEPekmezovicTExpression of Th1 and Th17 cytokines and transcription factors in multiple sclerosis patients: Does baseline T-bet mRNA predict the response to interferon-beta treatmentJ Neuroimmunol20092151–2909519695714
   PubMed Web of Science ®Google Scholar
• MannonPJFussIJMayerLAnti-interleukin-12 antibody for active Crohn’s diseaseN Engl J Med2004351202069207915537905
   PubMed Web of Science ®Google Scholar
• FussIJBeckerCYangZBoth IL-12p70 and IL-23 are synthesized during active Crohn’s disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibodyInflamm Bowel Dis200612191516374252
   PubMed Web of Science ®Google Scholar
• SandbornWJFeaganBGFedorakRNA randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn‘s diseaseGastroenterology200813541130114118706417
   PubMed Web of Science ®Google Scholar
• BurakoffRBarishCFRiffDA phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn’s diseaseInflamm Bowel Dis200612755856516804392
   PubMed Web of Science ®Google Scholar
• KruegerGGLangleyRGLeonardiCA human interleukin- 12/23 monoclonal antibody for the treatment of psoriasisN Engl J Med2007356658059217287478
   PubMed Web of Science ®Google Scholar
• KimballABGordonKBLangleyRGMenterAChartashEKValdesJSafety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: Results of a randomized, placebo-controlled, phase 2 trialArch Dermatol2008144220020718283176
   PubMedGoogle Scholar
• LeonardiCLKimballABPappKAEfficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)Lancet200837196251665167418486739
   PubMed Web of Science ®Google Scholar
• GriffithsCEStroberBEvan de KerkhofPComparison of ustekinumab and etanercept for moderate-to-severe psoriasisN Engl J Med2010362211812820071701
   PubMed Web of Science ®Google Scholar
• SegalBMConstantinescuCSRaychaudhuriAKimLFidelus-GortRKasperLHRepeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: A phase II, double-blind, placebo-controlled, randomised, dose-ranging studyLancet Neurol20087979680418703004
   PubMed Web of Science ®Google Scholar
• ChenYLangrishCLMcKenzieBAnti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitisJ Clin Invest200611651317132616670771
   PubMed Web of Science ®Google Scholar
• GenoveseMVan den BoschFRobersonSLY2439821, a humanized anti-IL-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritisArthritis Rheum201062492993920131262
   PubMed Web of Science ®Google Scholar